Peter Feinberg - 03 Oct 2025 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Peter Feinberg
Issuer symbol
IMRX
Transactions as of
03 Oct 2025
Net transactions value
+$50,025
Form type
4
Filing time
07 Oct 2025, 08:56:12 UTC
Previous filing
01 Oct 2025
Next filing
02 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Feinberg Peter Director 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE /s/ Michael D. Bookman, Attorney-in-Fact for Peter Feinberg 07 Oct 2025 0001870076

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Purchase $50,025 +7,500 +5% $6.67 156,766 03 Oct 2025 Direct
holding IMRX Class A Common Stock 392,242 03 Oct 2025 General Partner of PF Associates L.P.
holding IMRX Class A Common Stock 476,615 03 Oct 2025 General Partner of PEF LLC.
holding IMRX Class A Common Stock 115,441 03 Oct 2025 General Partner of S4K Investments LLC.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.